Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.

MLA

Lucas, Matthew C., et al. “Design, Synthesis, and Biological Evaluation of New Monoamine Reuptake Inhibitors with Potential Therapeutic Utility in Depression and Pain.” Bioorganic & Medicinal Chemistry Letters, vol. 20, no. 18, Sept. 2010, pp. 5559–66. EBSCOhost, https://doi.org/10.1016/j.bmcl.2010.07.020.

APA

Lucas, M. C., Weikert, R. J., Carter, D. S., Cai, H.-Y., Greenhouse, R., Iyer, P. S., Lin, C. J., Lee, E. K., Madera, A. M., Moore, A., Ozboya, K., Schoenfeld, R. C., Steiner, S., Zhai, Y., & Lynch, S. M. (2010). Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain. Bioorganic & Medicinal Chemistry Letters, 20(18), 5559–5566. https://doi.org/10.1016/j.bmcl.2010.07.020

Chicago

Lucas, Matthew C, Robert J Weikert, David S Carter, Hai-Ying Cai, Robert Greenhouse, Pravin S Iyer, Clara J Lin, et al. 2010. “Design, Synthesis, and Biological Evaluation of New Monoamine Reuptake Inhibitors with Potential Therapeutic Utility in Depression and Pain.” Bioorganic & Medicinal Chemistry Letters 20 (18): 5559–66. doi:10.1016/j.bmcl.2010.07.020.